Table 5 Red cell transfusion rates and bleeding complication.

From: Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children

Variables

All patient (n = 131)

Citrate group (n = 55)

Heparin group (n = 76)

p

Red blood cell transfused patient, n (%)

87 (66.4)

32 (58.2)

55 (72.4)

0.131

Transfused red blood cell units during CRRT, median (IQR)

1.0 (0.8–2.0)

1.0 (0.8–2.0)

1.0 (0.7–1.5)

1.000

Number of transfusion after circuit clotting / total number of transfusions, n (%)

39/137 (28.5)

8/64 (12.5)

31/73 (42.5)

< 0.0001

Severe bleeding event, n (%)

20 (15.3)

6 (10.9)

14 (18.4)

0.350

Type of bleeding event, n (%)

    

  Catheter insertion

17 (13.0)

4 (7.3)

13 (17.1)

0.165

  Gastrointestinal bleeding

7 (5.3)

2 (3.6)

5 (6.6)

0.698

  1. CRRT Continuous renal replacement therapy, IQR Interquartile range.
Back to article page